Michael D. Wendt Protein-Protein Interactions as Drug Targets Shaomeng Wang Yujun Zhao
Denzil Bernard Angelo Aguilar Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein
Interaction for New Cancer Therapeutics Kurt Deshayes Jeremy Murray Domagoj Vucic The
Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow David
R. Langley Nicholas A. Meanwell Michael A. Walker Kap-Sun Yeung Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell David R.
Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion ¿ a Focus on
Respiratory Syncytial Virus Andrew B. Mahon Stephen E. Miller Stephen T. Joy Paramjit S.
Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein
Interfaces Michael D. Wendt The Discovery of Navitoclax a Bcl-2 Family Inhibitor
